According to Iridex Corp., the study confirms MicroPulse TLT's sustained safety and efficacy in managing glaucoma, reducing ...

Iridex (IRIX) announced the publication of a peer-reviewed study in Ophthalmology Therapy. This study highlights the sustained safety and ...

What are eye floaters and what causes them? "Consider the eye as a bag of water with a clear window called the cornea in the ...

Diabetic retinopathy can lead to peripheral or nighttime vision loss, visual disturbances, and, if left untreated, blindness.

Some of the key market players operating in the ophthalmic lasers market include Alcon, IRIDEX, Alna-Medicalsystem, BAUSCH + LOMB, Lumenis Be Ltd., Abbott, NIDEK, MERIDIAN, Johnson & Johnson Vision, ...

The acquisition strengthens Bausch + Lomb's existing portfolio of surgical and pharmaceutical glaucoma treatments.

Legislation under consideration in Trenton could modernize the scope of access to modern eye care in New Jersey.

Many eye conditions can be easily treated if those at risk undergo regular eye examinations, and are informed about good ...

Bausch + Lomb announced today that an affiliate acquired Elios Vision, developer of a minimally invasive glaucoma surgery ...

Bausch + Lomb announced the acquisition of the ELIOS system, a laser-based technology that offers a new approach to treating ...

Bausch + Lomb Corporation (BLCO) has released an update.Pick the best stocks and maximize your portfolio:Discover top-rated stocks from highly ...

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that an affiliate has acquired Elios Vision, Inc.